Pacira | PCRX - Ativos





Ativos Alterar Data
Assertio Holdings USD 319.77M 46M 2025-09
Astellas Pharma JPY 3.6T 153.62B 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Cara Therapeutics USD 39.02M 4.73M 2025-09
Coherus Biosciences USD 258.34M 258.18M 2025-12
Heron Therapeutics USD 255.88M 6.93M 2025-12
Ironwood Pharmaceuticals USD 396.06M 53.12M 2025-09
J&J USD 199.21B 6.39B 2025-12
Ligand Pharmaceuticals USD 1.56B 83.86M 2025-12
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Novo Nordisk DKK 542.9B 30.61B 2025-12
Omeros USD 200.57M 34.59M 2025-06
Pacira USD 1.26B 32.66M 2025-12
Perrigo USD 8.54B 1.55B 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Supernus Pharmaceuticals USD 1.45B 32.89M 2025-12
Teva Pharmaceutical Industries USD 40.75B 892M 2025-12
Xeris Pharmaceuticals USD 383.53M 13.34M 2025-12
Xoma USD 263.15M 39.7M 2025-09
Zoetis USD 15.47B 308M 2025-12